Chemotherapy disrupts bone remodeling by impairing osteoblast activity, enhancing osteoclast function, and reducing sex hormones. Bone density often declines progressively without intervention, even post-treatment. Clinical strategies such as pharmacologic therapy, nutrient supplementation, and weight-bearing activity are key in mitigating skeletal complications during and after chemotherapy.